Copyright © 2021
*Depending on the stage of glaucoma, a clinical treatment switch from one drug to a combination of drugs can be required.
All our product candidates aim to enhance patient quality of life and are based on clinical unmet need identified by internationally renowned KOL’s
We manage all the expertise and processes, from the idea to the market
Creation of high-quality long-term employment and significant contribution to the economic redeployment of Wallonia. Eyed’s team is today composed of 66 FTEs
Our technological platform allows to give access to long term innovative ophthalmological treatments to developing countries populations, where glaucoma is the second cause of blindness